PAPER Wang Y, Thinakaran G, Kar S
SEARCH RESULTS
330907 RESULTS
PAPER Xu DE, Zhang WM, Yang ZZ, Zhu HM, Yan K, Li S, Bagnard D, Dawe GS, Ma QH, Xiao ZC
Amyloid precursor protein at node of Ranvier modulates nodal formation.
Cell Adh Migr. 2014 Apr 11;8(4) PubMed: 24846210PAPER Ascaso FJ, Cruz N, Modrego PJ, Lopez-Anton R, Santabárbara J, Pascual LF, Lobo A, Cristóbal JA
Retinal alterations in mild cognitive impairment and Alzheimer's disease: an optical coherence tomography study.
J Neurol. 2014 Aug;261(8):1522-30. Epub 2014 May 21 PubMed: 24846203PAPER Zemek F, Drtinova L, Nepovimova E, Sepsova V, Korabecny J, Klimes J, Kuca K
Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine.
Expert Opin Drug Saf. 2014 Jun;13(6):759-74. PubMed: 24845946PAPER Provia J, Jeynes B
Reduction in Vascular Endothelial Growth Factor Expression in the Superior Temporal, Hippocampal, and Brainstem Regions in Alzheimer's Disease.
Curr Neurovasc Res. 2014 May 20; PubMed: 24845858PAPER Ghoshal N, Perry A, McKeel D, Schmidt RE, Carter D, Norton J, Zou WQ, Xiao X, Puoti G, Notari S, Gambetti P, Morris JC, Cairns NJ
Variably Protease-sensitive Prionopathy in an Apparent Cognitively Normal 93-Year-Old.
Alzheimer Dis Assoc Disord. 2014 May 19; PubMed: 24845762PAPER Callahan CM, Tu W, Stump TE, Clark DO, Unroe KT, Hendrie HC
Errors in Self-Reports of Health Services Use: Impact on Alzheimer Disease Clinical Trial Designs.
Alzheimer Dis Assoc Disord. 2014 May 19; PubMed: 24845761PAPER Sanchez-Espinosa MP, Atienza M, Cantero JL
Sleep deficits in mild cognitive impairment are related to increased levels of plasma amyloid-β and cortical thinning.
Neuroimage. 2014 Sep;98:395-404. Epub 2014 May 16 PubMed: 24845621PAPER Zhang L, Liu C, Wu J, Tao JJ, Sui XL, Yao ZG, Xu YF, Huang L, Zhu H, Sheng SL, Qin C
Tubastatin A/ACY-1215 improves cognition in Alzheimer's disease transgenic mice.
J Alzheimers Dis. 2014;41(4):1193-205. PubMed: 24844691PAPER Maroof N, Ravipati S, Pardon MC, Barrett DA, Kendall DA
Reductions in endocannabinoid levels and enhanced coupling of cannabinoid receptors in the striatum are accompanied by cognitive impairments in the AβPPswe/PS1ΔE9 mouse model of Alzheimer's disease.
J Alzheimers Dis. 2014;42(1):227-45. PubMed: 24844690PAPER Suszyńska-Zajczyk J, Luczak M, Marczak L, Jakubowski H
Inactivation of the paraoxonase 1 gene affects the expression of mouse brain proteins involved in neurodegeneration.
J Alzheimers Dis. 2014;42(1):247-60. PubMed: 24844689PAPER Ghosh D, Brewer GJ
External cys/cySS redox state modification controls the intracellular redox state and neurodegeneration via Akt in aging and Alzheimer's disease mouse model neurons.
J Alzheimers Dis. 2014;42(1):313-24. PubMed: 24844688PAPER Bondi MW, Edmonds EC, Jak AJ, Clark LR, Delano-Wood L, McDonald CR, Nation DA, Libon DJ, Au R, Galasko D, Salmon DP
Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates.
J Alzheimers Dis. 2014;42(1):275-89. PubMed: 24844687PAPER Müller U, Winter P, Bolender C, Nolte D
Previously unrecognized missense mutation E126K of PSEN2 segregates with early onset Alzheimer's disease in a family.
J Alzheimers Dis. 2014;42(1):109-13. PubMed: 24844686PAPER Maya-Vetencourt JF, Carucci NM, Capsoni S, Cattaneo A
Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5XFAD transgenic model of Alzheimer's disease.
J Alzheimers Dis. 2014;42(1):103-7. PubMed: 24844685Current Filters
No filters selected